Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.23.10.1478PMID 11023140
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Urinary albumin excretion in families with type 2 diabetes is heritable and genetically correlated to blood pressure.

  2000cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Ethnic Differences in the Glycemic Response to Exogenous Insulin Treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM)

  1998cited by this paper
• A Critical Issue: Intensive insulin treatment and macrovascular disease

  1998cited by this paper
• Response to Intensive Therapy Steps and to Glipizide Dose in Combination With Insulin in Type 2 Diabetes: VA feasibility study on glycemic control and complications (VA CSDM)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Some answers, more controversy, from UKPDS

  1998cited by this paper
• Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.

  1998cited by this paper
• Acute excited states and sudden death

  1997cited by this paper
• Determinants of Progression of Microalbuminuria in Patients With NIDDM: A prospective study

  1997cited by this paper
• Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes.

  1997cited by this paper
• Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.

  1997cited by this paper
• Microalbuminuria in Patients With NIDDM: An Overview

  1996cited by this paper
• Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus

  1996cited by this paper
• Hyperinsulinemia as an independent risk factor for ischemic heart disease.

  1996cited by this paper
• Evaluations of Retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): A feasibility study

  1996cited by this paper
• Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.

  1995cited by this paper
• Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): Results of the feasibility trial

  1995cited by this paper
• Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.

  1995cited by this paper
• Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

  1995cited by this paper
• Effects of Long-Term Enalapril Treatment on Persistent Microalbuminuria in Well-Controlled Hypertensive and Normotensive NIDDM Patients

  1994cited by this paper
• NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects

  1994cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Long-Term Stabilizing Effect of Angiotensin-Converting Enzyme Inhibition on Plasma Creatinine and on Proteinuria in Normotensive Type II Diabetic Patients

  1993cited by this paper
• Systolic Blood Pressure Relates to the Rate of Decline of Glomerular Filtration Rate in Type II Diabetes

  1993cited by this paper
• Glycemic Control and Complications in Type II Diabetes: Design of a feasibility trial

  1992cited by this paper
• Type II diabetes mellitus: is the renal risk adequately appreciated?

  1991cited by this paper
• Antihypertensive Therapy With Ca2+: Antagonist Verapamil and/or ACE Inhibitor Enalapril in NIDDM Patients

  1991cited by this paper
• The Natural History and Associations of Microalbuminuria in Type 2 Diabetes During the First Year After Diagnosis

  1990cited by this paper
• Prevalence and Risk Factors for Micro- and Macroalbuminuria in Diabetic Subjects and Entire Population of Nauru

  1989cited by this paper
• Albuminuria in Type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in Pima Indians

  1989cited by this paper
• Recommendations for blood pressure determination by sphygmomanometry.

  1988cited by this paper
• The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics.

  1988cited by this paper
• Evaluation of a New Radioimmunoassay for Urinary Albumin

  1986cited by this paper
• Measured versus Estimated Creatinine Clearance in the Elderly as an Index of Renal Function

  1980cited by this paper
• The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

  1976cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Prevalence and risk factors of poor glycemic control and diabetic nephropathy among patients with type 2 diabetes mellitus in Dhamar, Yemen

  2024cites this paper
• Poor glycemic control is associated with more rapid kidney function decline after the onset of diabetic kidney disease.

  2024cites this paper
• Prevalence of Microalbuminuria in Type 2 Diabetes Mellitus

  2024cites this paper
• Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

  2024cites this paper
• A proposal from the Liver Forum for the management of comorbidities in nonalcoholic steatohepatitis therapeutic trials.

  2023cites this paper
• Managing comorbidities in chronic kidney disease reduces utilization and costs

  2023cites this paper
• Association between albuminuria and retinal microvascular dysfunction in type 2 diabetes with and without hypertension.

  2023cites this paper
• Efficacy and safety of intensive versus conventional glucose targets in people with type 2 diabetes: a systematic review and meta-analysis

  2023cites this paper
• Historical Background of Diabetic Kidney Disease

  2022cites this paper
• Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: A meta-analysis of randomised control-trials.

  2021cites this paper
• Prevalent vascular complications in people with diabetes: a multicentre observational cohort study

  2021cites this paper
• Evaluation of serum endocan as a marker of diabetic nephropathy

  2021cites this paper
• Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes

  2020cites this paper
• The association between albuminuria and thyroid antibodies in newly diagnosed type 2 diabetes mellitus patients with Hashimoto’s thyroiditis and euthyroidism

  2020cites this paper
• MICROALBUMINURIA AND ITS SIGNIFICANCE IN VASCULAR COMPLICATIONS IN DIABETIC PATIENTS RECEIVING ORAL HYPOGLYCEMIC DRUGS.

  2019cites this paper
• Beneficial role of magnesium valproate in diabetic nephropathy associated with renal fibrosis in experimental animals

  2019cites this paper
• Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria

  2018cites this paper
• Effects of intensive interventions compared to standard care in people with type 2 diabetes and microalbuminuria on risk factors control and cardiovascular outcomes: A systematic review and meta-analysis of randomised controlled trials.

  2018cites this paper
• Management of Diabetes in the Pre-End-Stage Renal Disease and Chronic Kidney Disease

  2017cites this paper
• Glucose targets for preventing diabetic kidney disease and its progression.

  2017cites this paper
• Concepts in Diabetic Nephropathy: From Pathophysiology to Treatment

  2017cites this paper
• Prevalence of Microalbuminuria in Patients with Type 2 Diabetes Mellitus

  2017cites this paper
• Clinical and pathological factors associated with progression of diabetic nephropathy

  2017cites this paper
• Elderly patients with glomerular diseases and IgA nephropathy

  2017cites this paper
• C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

  2016cites this paper
• Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis

  2016cites this paper
• Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline.

  2016cites this paper
• Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.

  2015cites this paper
• Management of diabetes mellitus in patients with chronic kidney disease

  2015cites this paper
• Impact of ethnicity on progress of glycaemic control in 131 935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register

  2015cites this paper
• Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths

  2015cites this paper
• Nonadherence of Oral Antihyperglycemic Medication Will Increase Risk of End-Stage Renal Disease

  2015cites this paper
• Distinct HbA1c trajectories in a type 2 diabetes cohort

  2015cites this paper
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

  2015cites this paper
• Prevention of diabetic microvascular complications

  2015cites this paper
• Importância clínica da microalbuminúria: breve revisão sobre sua utilidade no diagnóstico precoce, prognóstico e avaliação terapêutica de doenças cardiovasculares.

  2015cites this paper
• Screening for Type 2 Diabetes

  2015cites this paper
• Particularidades no manejo do diabetes em pacientes nefropatas

  2015cites this paper
• WITHDRAWN: Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.

  2015cites this paper
• Diagnosis and Treatment of Diabetic Kidney Disease

  2014cites this paper
• Association of Microalbuminuria with Ischemic Heart Disease, Dyslipidemia and Obesity among Diabetic Patients: Experience from 5 Year Follow up Study of 1415 Patients

  2014cites this paper
• The Background History of Diabetic Nephropathy

  2014cites this paper
• Clinical Factors Associated With the Diagnosis and Progression of Diabetic Nephropathy

  2014cites this paper
• Diagnosis and treatment of early stages of diabetic nephropathy

  2014cites this paper
• Use of Available Glucose-Lowering Agents in Patients with Different Levels of Renal Impairment

  2013cites this paper
• Glycated haemoglobin and the risk of cardiovascular disease, diabetes and all‐cause mortality in the Copenhagen City Heart Study

  2013cites this paper
• The Impact of Point-of-Care A1C Testing on Provider Compliance and A1C Levels in a Primary Setting

  2013cites this paper
• Diabetes Mellitus Type 2 and Proteinuria

  2013cites this paper
• Reducing renal failure: how low do glucose levels need to go?

  2012cites this paper
• Disease High burden and unmet patient needs in chronic kidney disease

  2012cites this paper
• Chronic kidney disease in type 2 diabetes patients in France: prevalence, influence of glycaemic control and implications for the pharmacological management of diabetes.

  2012cites this paper
• High burden and unmet patient needs in chronic kidney disease

  2012cites this paper
• Diabetic nephropathy among Mexican Americans

  2012cites this paper
• Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes.

  2012cites this paper
• Effectiveness for self-monitoring of blood sugar on blood glucose control in Turkish patients with type 2 diabetes mellitus.

  2012cites this paper
• KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.

  2012cites this paper
• Comparative effectiveness of incident oral antidiabetic drugs on kidney function

  2012cites this paper
• Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

  2011cites this paper
• Managing chronic kidney disease in type 2 diabetes in family practice.

  2011cites this paper
• Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

  2011cites this paper
• Intensive glycemic control and renal outcome.

  2011cites this paper
• Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial

  2011cites this paper
• [Diabetic nephropathy and cardiovascular risk].

  2010cites this paper
• Prevention and management of chronic kidney disease in type 2 diabetes

  2010cites this paper
• Prevention and management of chronic kidney disease in type 2 diabetes

  2010cites this paper
• A propósito de la adecuación de la demanda. Nefropatía diabética

  2010cites this paper
• Nefropatía diabética y riesgo cardiovascular

  2010cites this paper
• Intensive glycemic control and macrovascular events in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials.

  2010cites this paper
• Microalbuminuria in diabetes mellitus: Association with age, sex, weight, and creatinine clearance

  2009cites this paper
• Fibrates and microvascular complications in diabetes--insight from the FIELD study.

  2009cites this paper
• Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report

  2009cites this paper
• Guidelines for the management of chronic kidney disease

  2008cites this paper
• Socioeconomic status and the incidence of ESRD.

  2008cites this paper
• New Recommendations for the Management of Diabetic Kidney Disease

  2008cites this paper
• Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes

  2007cites this paper
• Microalbuminuria: utilidad clínica y manejo en la diabetes mellitus tipo 2 (parte I)

  2007cites this paper
• The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in isfahan, iran.

  2007cites this paper
• A COMMUNITY-BASED SCREENING CAMPAIGN FOR THE DETECTION OF DIABETES MELLITUS AND HYPERTENSION IN THE EASTERN PROVINCE, SAUDI ARABIA: METHODS AND PARTICIPATION RATES

  2007cites this paper
• Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin

  2006cites this paper
• Screening and Treatment of Early Diabetic Renal Disease in Type 1 and Type 2 Diabetes

  2006cites this paper
• The association between metabolic control and prevalent macrovascular disease in Type 2 diabetes: the VA Cooperative Study in diabetes.

  2006cites this paper
• Provider deferred decisions on hemoglobin A1c results: a report from the Colorado Research Network (CaReNet) and the High Plains Research Network (HPRN).

  2006cites this paper
• Principles and Guidelines of a Curriculum for Education of the Ophthalmic Specialist

  2006cites this paper
• Effektivität des PROSIT-Interventionsprogramms in Bezug auf die Blutglukoseeinstellung bei Typ 2-diabetischen Patienten

  2005influential citation
• Evaluating the Cardiovascular Effects of the Thiazolidinediones and Their Place in the Management of Type 2 Diabetes in Relation to the Metabolic Syndrome

  2005cites this paper
• A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects

  2005cites this paper
• Systematic review on urine albumin testing for early detection of diabetic complications.

  2005cites this paper
• Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.

  2005cites this paper
• Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study.

  2005cites this paper
• Evaluation of the UCL Diabetes Self-management Programme (UCL-DSMP): A Randomized Controlled Trial

  2005cites this paper
• Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.

  2004cites this paper
• Microalbuminuria como indicador precoz de Hipertrofia Ventricular Izquierda en pacientes diabéticos tipo 1 y 2, no hipertensos

  2004cites this paper
• Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany.

  2004cites this paper
• The edematogenic properties of insulin.

  2004cites this paper
• Clinical decisions regarding HbA1c results in primary care: a report from CaReNet and HPRN.

  2004cites this paper
• The role of polymorphisms in chemokines and chemokine receptors in the clinical course of HIV-1 infection

  2004cites this paper
• From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria.

  2004cites this paper
• Rosiglitazone reduces urinary albumin excretion in type II diabetes

  2003cites this paper
• Effect of intensive therapy of multiple factors intervention on vascular complications in type 2 diabetes

  2003cites this paper
• Caracterização de portadores de diabetes mellitus tipo 2 quanto ao tratamento clínico -nutricional e risco de complicações

  2003cites this paper